Search

Your search keyword '"GvHD"' showing total 3,773 results

Search Constraints

Start Over You searched for: Descriptor "GvHD" Remove constraint Descriptor: "GvHD"
3,773 results on '"GvHD"'

Search Results

1. Comparison of two inline photopheresis systems: A paired crossover trial.

2. Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioning: a double-blind randomized study and literature review.

Catalog

Books, media, physical & digital resources

3. Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation

4. Transfusion‐Associated Graft‐Versus‐Host Disease in Pediatric Patients: Clinical Features and Outcomes.

5. Development and Clinical Validation of Liquid Chromatography–Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid‐Refractory Graft‐Versus‐Host Disease: A First Step Towards Optimized Treatment.

6. Quantifying HLA Mismatches at Epitope Level in Haplo‐HSCT: Impact in the Outcome in Strategies Using PTCy.

7. Aspergillus calidoustus and Talaromyces columbinus infections in chronic graft-versus-host disease.

8. Narrative Review: Advancing Dysbiosis Treatment in Onco-Hematology with Microbiome-Based Therapeutic Approach.

9. The Impact of FDA-Approved Novel Agents for Steroid-Refractory Chronic Graft vs. Host Disease on Treatment Patterns and Outcomes—A Single-Center Longitudinal Cohort Analysis.

10. Impact of Allogeneic Stem Cell Transplant on Safety and Outcomes of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Patients with Multiple Myeloma (MM).

11. International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges.

12. Oral acute graft‐versus‐host disease

13. Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

14. Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioning: a double-blind randomized study and literature review

15. Pathophysiology and preclinical relevance of experimental graft-versus-host disease in humanized mice

17. Mucormycosis in solid organ transplant recipients (clinical cases and literature review)

18. Chronic Ocular GVHD Treatment at Two Locations of a Tertiary Referral Center

19. Recent updates on allogeneic CAR-T cells in hematological malignancies

20. Recent updates on allogeneic CAR-T cells in hematological malignancies.

21. Extracorporeal Photopheresis in Pediatric and Adult Patients with Graft-Versus-Host Disease.

22. A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose.

23. Immune reactions following intestinal transplantation: Mechanisms and prevention.

24. Diagnostic Challenges and Emerging Pathogeneses of Selected Glomerulopathies.

25. Traversing the bench to bedside journey for iNKT cell therapies.

26. The Impact of Histologic Portal T-Cell Density on the Clinical Outcomes in Hepatic Graft-versus-Host Disease and Autoimmune Liver Diseases.

27. Post‐transplant‐cyclophosphamide and short‐term Everolimus as graft‐versus‐host‐prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the phase II OCTET‐EVER trial.

28. A Study of the Relationship of the Dynamics of Development and Characteristics of Chimerism with Manifestations of Graft-vs.-Host Disease in the Organs of Mice after Allogeneic Transplantation of Whole Bone Marrow.

29. Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study.

30. Haploidentical Stem Cell Transplantation: Half Match but More Hope!—Single Centre Experience from Western India.

31. Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes

32. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review

33. Topical 5‐fluorouracil 4% resolves anti‐PD‐1 induced keratoacanthomas in enteropathy‐associated T‐cell lymphoma allogeneic transplant patient.

36. Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) – Case series

37. Abstracts of the Cell Therapy Transplant Canada 2023 Annual Conference

38. Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial

39. Mucosal-associated invariant T cells for cancer immunotherapy

40. Optimizing Outcomes in Mismatched Unrelated Donor Allogeneic Transplantation: Post-Transplant Cyclophosphamide's Dual Impact on Graft versus Host Disease Incidence and Overall Survival: Retrospective Analysis on Behalf of Polish Adult Leukemia Group.

41. Haploidentical HSCT in the Treatment of Pediatric Hematological Disorders.

42. Encephalitozoon hellem infection after haploidentical allogeneic hematopoietic stem cell transplantation in children: a case report.

43. Early Tapering of Cyclosporine Is Feasible in Haploidentical Stem Cell Transplantation: A Single Center Experience.

44. Clinical and Economic Impact of CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation: Perspectives from a Middle‐Income Nation.

45. Abstracts of the Cell Therapy Transplant Canada 2023 Annual Conference.

46. Grading Histopathology Features of Graft-versus-host Disease in Animal Models: A Systematic Review.

47. The impact of regulatory T cells on the graft-versus-leukemia effect.

48. HLA peptide‐binding pocket diversity modulates immunological complications after cord blood transplant in acute leukaemia.

49. Immunomodulation of salivary gland function due to cancer therapy.

50. Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial.